Seasoned investor and operating executive focused on growth-stage and middle-market opportunities across technology and industrials. John Derrick leverages corporate finance and M&A experience to source deals, lead operational turnarounds, and serve on boards. Known for hands-on portfolio management, capital structure optimization and exit planning, often working with PE sponsors, strategic acquirers and management teams to drive scaled revenue and margin expansion.
Seasoned investor and operating executive focused on growth-stage and middle-market opportunities across technology and industrials. John Derrick leverages corporate finance and M&A experience to source deals, lead operational turnarounds, and serve on boards. Known for hands-on portfolio management, capital structure optimization and exit planning, often working with PE sponsors, strategic acquirers and management teams to drive scaled revenue and margin expansion.
Targets growth-stage and middle-market companies in technology and industrials, deploying a hands-on, operationally driven private equity style. Prefers control or significant minority positions that enable active board involvement, capital structure optimization and performance turnarounds. Investment horizon is medium-term with value creation via revenue scaling, margin expansion and selective M&A. Underwrites with rigorous corporate finance and cash-flow disciplines, partners with PE sponsors and strategic acquirers, and prioritizes clear exit pathways to maximize realized IRR.
Targets growth-stage and middle-market companies in technology and industrials, deploying a hands-on, operationally driven private equity style. Prefers control or significant minority positions that enable active board involvement, capital structure optimization and performance turnarounds. Investment horizon is medium-term with value creation via revenue scaling, margin expansion and selective M&A. Underwrites with rigorous corporate finance and cash-flow disciplines, partners with PE sponsors and strategic acquirers, and prioritizes clear exit pathways to maximize realized IRR.
| Trades 311 | Longs Won 210/311 67% | Profit Factor 5.26 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.84M |
| Average Win $908,860.82 | Best Trade (Oct 27) $12.96M | Sharpe Ratio -12.08 |
| Average Loss -$359,218.57 | Worst Trade (Oct 14) -$4M | Z-Score 8.82 (100%) |
| Commissions $0 | Avg. Trade Length 1y 4m 2w 5d | Expectancy $497,040.83 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 1,280 | 1,152 | 1,024 | 896 | 768 | 640 | 512 | 384 | 256 | 128 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ACN Accenture plc | 56,458 | $16.95M | $13.31M | - | -$3.64M | -21.47% | -4.645% |
ASML ASML Holding N.V. NY Registered Shares | 13,973 | $11.36M | $22.83M | - | $11.47M | 100.92% | +2.818% |
BNS Bank of Nova Scotia | 206,843 | $10.58M | $19.4M | - | $8.82M | 83.42% | +0.547% |
BRK-B Berkshire Hathaway Inc. | 30,915 | $12.09M | $16.85M | - | $4.76M | 39.41% | -0.62% |
CALM Cal-Maine Foods, Inc. | 126,065 | $8.19M | $7.69M | - | -$498,635.14 | -6.09% | -2.158% |
CMI Cummins Inc. | 27,005 | $7.75M | $14.26M | - | $6.51M | 84.02% | +1.103% |
COF Capital One Financial Corp. | 63,439 | $13.41M | $12.99M | - | -$420,358.08 | -3.13% | +1.201% |
DE Deere & Company | 30,854 | $14.78M | $19.77M | - | $4.99M | 33.75% | -0.097% |
EMR Emerson Electric Co. | 104,408 | $10.78M | $17.21M | - | $6.43M | 59.66% | +1.954% |
GOOG Alphabet Inc | 1,218 | $216,061 | $386,761.53 | - | $170,700.53 | 79.01% | +1.066% |
GOOGL Alphabet Inc | 74,950 | $12.14M | $24.06M | - | $11.92M | 98.19% | +1.348% |
IBOC International Bancshares Corp. | 127,460 | $7.16M | $8.57M | - | $1.41M | 19.77% | +0.689% |
ICLR ICON plc | 135,223 | $20.67M | $24.73M | - | $4.06M | 19.64% | -0.506% |
JBHT J.B. Hunt Transport Services, Inc. | 85,567 | $13.46M | $19.62M | - | $6.16M | 45.75% | +2.169% |
LRCX Lam Research Corp. | 71,685 | $6.84M | $17.22M | - | $10.37M | 151.61% | +1.133% |
MRK Merck & Co., Inc. | 117,403 | $12.89M | $16.67M | - | $3.78M | 29.33% | +0.953% |
MTN Vail Resorts Inc. | 70,516 | $9.38M | $10.61M | - | $1.23M | 13.13% | +0.723% |
NVO Novo Nordisk A/S Sponsored ADR | 164,867 | $15.1M | $6.38M | - | -$8.72M | -57.73% | -1.073% |
NVS Novartis AG Sponsored ADR | 81,260 | $9.01M | $12.65M | - | $3.64M | 40.42% | +1.18% |
PEP PepsiCo, Inc. | 80,677 | $12.63M | $10.73M | - | -$1.9M | -15.05% | -1.834% |